Anagenics Ltd
AN1
Company Profile
Business description
Anagenics Ltd is a health wellness and beauty business servicing wholesale and retail customers through omnichannel, offering premium branded products. It develops and sells differentiated and clinically validated solutions for a range of conditions associated with aging. It includes validated consumer products to help people live longer, in good health, and with confidence. Its brands include Evolis and Uspa.
Contact
55 Clarence Street
Suite 204, Level 2
SydneyNSW2000
AUST: +61 292216830
Sector
Consumer Defensive
Stock type
Defensive
Industry
Household & Personal Products
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
Ahead of earnings, is Nvidia a buy, a sell, or fairly valued?
Amid robust demand for semis, watch for any impact of in-house built chips and whether the supply chain is on track.
stocks
Higher interest rates boost earnings for ASX real estate platform
Interest rates are driving a spike in property listings.
stocks
After earnings, is Palantir a buy, a sell, or fairly valued?
With uncertainty regarding its total addressable market and competitive threats, here’s what we think of Palantir stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,880.70 | 7.70 | 0.09% |
| CAC 40 | 7,982.15 | 2.23 | 0.03% |
| DAX 40 | 24,087.02 | 132.09 | 0.55% |
| Dow JONES (US) | 49,505.08 | 255.48 | -0.51% |
| FTSE 100 | 10,301.25 | 35.93 | 0.35% |
| HKSE | 26,388.44 | 40.53 | 0.15% |
| NASDAQ | 26,122.41 | 34.21 | 0.13% |
| Nikkei 225 | 63,272.11 | 529.54 | 0.84% |
| NZX 50 Index | 13,063.06 | 17.27 | -0.13% |
| S&P 500 | 7,391.18 | 9.78 | -0.13% |
| S&P/ASX 200 | 8,630.40 | 0.60 | -0.01% |
| SSE Composite Index | 4,242.57 | 28.08 | 0.67% |